MedTrace Logo

Pulpotomy Materials in Primary Molars

NCT07120321 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-08-13

No results posted yet for this study

Summary

This randomized clinical trial aims to compare four different materials used in a dental procedure called pulpotomy. Pulpotomy is commonly performed on primary molars (back teeth in children) to treat deep cavities and preserve the tooth. Children aged 4 to 7 who need this procedure will receive one of four materials: Mineral Trioxide Aggregate (MTA), Biodentine, Ferric Sulfate, or Sodium Hypochlorite gel. The treated teeth will be checked at 6 and 12 months to evaluate the success of each material. The goal is to identify the most effective and reliable material for pulpotomy in primary molars.

Conditions

  • Dental Caries
  • Pulpitis

Interventions

DRUG

Mineral Trioxide Aggregate (MTA)

Used as the capping agent after coronal pulp removal in primary molars.

DRUG

Biodentine

Used as a bioactive pulpotomy agent following coronal pulp amputation.

DRUG

Ferric Sulfate

15.5% Ferric Sulfate applied to pulp stumps for 15 seconds during pulpotomy procedure.

DRUG

Sodium hypochlorite gel application

5% NaOCl gel applied to pulp tissue during pulpotomy for its hemostatic and disinfectant effects.

Sponsors & Collaborators

  • Inonu University

    collaborator OTHER

  • Sacide Duman

    lead OTHER

Principal Investigators

  • sacide duman, Assoc Prof · Inonu University, Faculty of Dentistry, Department of Pediatric Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-01-01
Completion
2025-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07120321 on ClinicalTrials.gov